ABSTRACT
Much of the debate on human enhancement technologies starts from the standpoint of traditional bioethics. The usual ethical principles applied are familiar to medicine, such as nonmalecence, the physician’s injunction to do no harm. But emerging technologies blur the line between what is medicine and what is engineering. In circumstances such as the human-enhancement debate, it is appropriate to use conceptual tools from engineering ethics as well, such as risk-benet analysis (RBA).
